Millions at Risk? Common Drug Linked to Significant Rise in Dementia Cases

Millions at Risk? Common Drug Linked to Significant Rise in Dementia Cases

Ian Maidment, a clinical pharmacy professor at Aston University in Birmingham, England, also pointed out that the analysis didn’t control for treatment duration or dosage. He added that other recent studies have failed to find a link, stating, “The jury is out on whether gabapentin causes dementia.”

Meanwhile, Dr. Neel Anand, a board-certified orthopedic spine surgeon not involved in the study, stressed that proving a direct cause would require comparing patients who use only gabapentin with those who don’t, while making sure the drug is taken as prescribed. Still, he noted that it’s important to be aware of possible cognitive risks tied to long-term use.

Post navigation

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

back to top